NQO1 Protein (NAD(P)H Quinone Dehydrogenase 1)

title: NQO1 Protein (NAD(P)H Quinone Dehydrogenase 1)

NQO1 (NAD(P)H Quinone Dehydrogenase 1) Protein

<div class="infobox infobox-protein">

| Property | Value |
|----------|-------|
| Protein Name | NAD(P)H quinone dehydrogenase 1 |
| Gene | NQO1 |
| UniProt ID | P15559 |
| PDB ID | 1QBG, 1R1M, 5EHA, 6BQD |
| Molecular Weight | ~31 kDa |
| Subcellular Localization | Cytoplasm, also nucleus (minor) |
| Protein Family | NAD(P)H dehydrogenase (quinone) family |
| Expression | Ubiquitous, high in brain, liver, kidney |

</div>

Overview

NAD(P)H quinone dehydrogenase 1 (NQO1), also known as DT-diaphorase, is a 274-amino acid flavoprotein that serves as a critical detoxification enzyme in cellular redox homeostasis. Uniquely among enzymes, NQO1 catalyzes two-electron reduction of quinones, bypassing the one-electron reduction that generates toxic semiquinone radicals[@bianchet2004]. This function is particularly important in the brain, where oxidative stress and quinone metabolism play central roles in neurodegeneration.

title: NQO1 Protein (NAD(P)H Quinone Dehydrogenase 1)

NQO1 (NAD(P)H Quinone Dehydrogenase 1) Protein

<div class="infobox infobox-protein">

| Property | Value |
|----------|-------|
| Protein Name | NAD(P)H quinone dehydrogenase 1 |
| Gene | NQO1 |
| UniProt ID | P15559 |
| PDB ID | 1QBG, 1R1M, 5EHA, 6BQD |
| Molecular Weight | ~31 kDa |
| Subcellular Localization | Cytoplasm, also nucleus (minor) |
| Protein Family | NAD(P)H dehydrogenase (quinone) family |
| Expression | Ubiquitous, high in brain, liver, kidney |

</div>

Overview

NAD(P)H quinone dehydrogenase 1 (NQO1), also known as DT-diaphorase, is a 274-amino acid flavoprotein that serves as a critical detoxification enzyme in cellular redox homeostasis. Uniquely among enzymes, NQO1 catalyzes two-electron reduction of quinones, bypassing the one-electron reduction that generates toxic semiquinone radicals[@bianchet2004]. This function is particularly important in the brain, where oxidative stress and quinone metabolism play central roles in neurodegeneration.

NQO1 is one of the most induced enzymes in response to oxidative stress, regulated primarily through the Nrf2-ARE (antioxidant response element) pathway. Its activity is essential for maintaining cellular redox balance, regenerating antioxidant compounds, and protecting against genotoxic stress. The common missense variant C609T (P187S), present in approximately 20% of the population, reduces NQO1 activity by approximately 70% and has been associated with increased risk for [Alzheimer's disease](/diseases/alzheimers-disease) and [Parkinson's disease](/diseases/parkinsons-disease)[@dinkova2015].

Structure

The NQO1 protein exhibits unique structural features that enable its distinctive catalytic function[@bianchet2004]:

Domain Architecture

• Rossmann Fold (aa 1-150): The N-terminal domain binds the NAD(P)H cofactor. Unlike most dehydrogenases, NQO1 shows equal affinity for NADH and NADPH, reflecting its role as a universal two-electron reductant.
• FAD Binding Site (aa 150-200): Contains a tightly bound FAD cofactor (1:1 stoichiometry). The FAD is covalently linked to a cysteine residue (Cys105) and is essential for catalysis. The isoalloxazine ring of FAD undergoes redox cycling during catalysis.
• Active Site (aa 180-230): The site of two-electron reduction. Contains key residues for substrate binding and catalysis, including Tyr128, Asp150, and His161.
• Proline-Rich Region (aa 80-100): A unique feature of NQO1 among the quinone oxidoreductase family, with multiple proline residues of unknown function.
• Dimeric Interface: NQO1 functions as a homodimer. Each monomer has a molecular weight of ~31 kDa, and the dimer has a total mass of ~62 kDa. Dimerization is required for stability and activity.

Catalytic Mechanism

The catalytic mechanism is unique:

Genetic Variants

| Variant | Frequency | Effect |
|---------|-----------|--------|
| C609T (P187S) | ~20% Caucasian | 70% reduced activity |
| R139W | Rare | Loss of function |
| P34S | Rare | Variable effect |

Normal Function in the Nervous System

NQO1 performs essential detoxification and antioxidant functions in neurons and glia:

Quinone Detoxification

• One-electron vs. two-electron reduction: Most enzymes reduce quinones via one electron, generating semiquinone radicals that react with oxygen to form superoxide. NQO1 performs direct two-electron reduction, avoiding ROS generation.
• Endogenous quinones: Metabolism of dopamine, norepinephrine, and other catecholamines generates quinones. NQO1 detoxifies these before they can form toxic oligomers or damage DNA.
• Exogenous quinones: Environmental quinones from pesticides, industrial chemicals, and drugs are also substrates for NQO1.

Antioxidant Defense

• Coenzyme Q10 (Ubiquinone) recycling: NQO1 reduces ubiquinone to ubiquinol, the active antioxidant form of coenzyme Q10. This is critical for mitochondrial electron transport chain protection.
• Vitamin E metabolism: Tocopherol quinone (the oxidized form of vitamin E) is reduced by NQO1 back to active tocopherol.
• Direct antioxidant effects: NQO1 can function as a direct antioxidant, quenching radicals through its flavin cofactor.

DNA and Protein Protection

• DNA protection: Prevents oxidative DNA damage by reducing quinone genotoxins before they can form DNA adducts.
• p53 stabilization: NQO1 stabilizes the tumor suppressor p53 by preventing its degradation, linking it to DNA damage responses.
• Protein protection: Prevents protein cross-linking and aggregation caused by quinone-derived carbonyls.

Mitochondrial Function

• ETC protection: By regenerating ubiquinol, NQO1 protects complex I and other components of the electron transport chain from oxidative damage.
• Membrane protection: Lipid peroxidation generates quinones that NQO1 can reduce, preventing chain reaction lipid peroxidation.

Cellular Signaling

• Nrf2 regulation: NQO1 is both a target and regulator of Nrf2, creating a positive feedback loop in antioxidant response.
• p53 pathway: NQO1-p53 interaction affects cell cycle and apoptosis decisions.

Role in Disease

Alzheimer's Disease (AD)

NQO1 deficiency contributes to AD pathogenesis through multiple interconnected mechanisms[@sanarico2019][@ross2018]:

Oxidative Stress

• Reduced quinone detoxification leads to accumulation of toxic quinone species
• Semiquinone formation from inefficient one-electron reduction increases ROS
• NQO1 activity is reduced in AD brain, correlating with disease severity
• The C609T variant is associated with increased AD risk

[Aβ](/proteins/amyloid-beta) (amyloid-beta) induces NQO1 deficiency:

• Aβ exposure reduces NQO1 expression in neurons
• Loss of NQO1 exacerbates Aβ-induced oxidative stress
• NQO1 activity correlates inversely with amyloid burden
• NQO1 can reduce Aβ-induced neurotoxicity in models

• Coenzyme Q10 depletion affects the electron transport chain
• Mitochondrial ROS increases, creating a vicious cycle
• NQO1 deficiency in AD brain correlates with complex I impairment
• Ubiquinol regeneration is critical for mitochondrial protection

• Quinone accumulation triggers microglial activation
• NQO1 modulates inflammatory responses in astrocytes
• NQO1 deficiency exacerbates neuroinflammation

• Coenzyme Q10: NQO1 substrates for mitochondrial support (multiple trials)
• Vitamin E: NQO1-mediated regeneration of tocopherol
• Nrf2 activators: Increase NQO1 expression (sulforaphane, bardoxolone methyl)
• Gene therapy: AAV-NQO1 in development

Parkinson's Disease (PD)

NQO1 has a particularly important role in PD due to dopamine metabolism:

Dopamine Quinones

• Dopamine oxidation generates dopamine quinones (DQ)
• NQO1 is the primary enzyme detoxifying DQ in dopaminergic neurons
• NQO1 activity is high in substantia nigra under normal conditions
• NQO1 deficiency allows DQ accumulation and neuronal death

• MPTP, 6-OHDA, and other parkinsonian toxins generate quinones
• NQO1 protects against these toxins in model systems
• NQO1 deficiency increases susceptibility to parkinsonian toxins

[NQO1 modulates alpha-synuclein](/proteins/alpha-synuclein) (α-syn) aggregation:

• Oxidative stress promotes α-syn oxidation and aggregation
• NQO1 can reduce α-syn oxidation and oligomerization
• NQO1 levels correlate inversely with α-syn pathology

• NQO1 polymorphisms modify PD risk
• C609T variant associated with earlier onset and faster progression
• Gene-environment interactions (e.g., pesticide exposure + variant)

• Nrf2 activators: Increase NQO1 expression
• Coenzyme Q10: Support mitochondrial function
• Quinone scavengers: Reduce quinone burden

Amyotrophic Lateral Sclerosis (ALS)

• NQO1 activity is reduced in ALS motor cortex and spinal cord
• Motor neurons have high oxidative stress and quinone production
• NQO1 deficiency may contribute to motor neuron vulnerability
• Therapeutic approaches mirror those in AD and PD

Huntington's Disease (HD)

• Mutant huntingtin impairs NQO1 function
• Quinone accumulation contributes to pathology
• NQO1 restoration shows benefit in HD models

Mechanism of Action

Detoxification Pathways

Nrf2-ARE Pathway

NQO1 is one of the premier Nrf2 target genes:

Coenzyme Q10 Cycle

Therapeutic Targeting

Clinical Status

| Approach | Status | Notes |
|----------|--------|-------|
| Coenzyme Q10 | Phase 2-3 | AD, PD, Huntington's trials |
| Nrf2 activators | Phase 2 | Sulforaphane, bardoxolone |
| Vitamin E | Completed | Mixed results |
| Gene therapy | Preclinical | AAV-NQO1 |

Experimental Approaches

Pharmacological Modulation

• Nrf2 activators: Sulforaphane, oltipraz, bardoxolone methyl
• Coenzyme Q10: Ubiquinol form better absorbed
• Vitamin E: Tocopherol form
• Direct NQO1 substrates: Increase activity

Gene Therapy

• AAV-NQO1: Adeno-associated virus delivery
• CRISPR activation: Increase endogenous expression
• Cell-targeted delivery: Focus on neurons

Combination Approaches

• Nrf2 activators + CoQ10
• NQO1 + other phase II enzymes
• Antioxidant + anti-inflammatory

Challenges

• Activity vs. expression: Measuring functional activity vs. protein levels
• BBB penetration: Some compounds don't cross blood-brain barrier
• C609T carriers: ~20% population has reduced NQO1 activity
• Redox balance: Too much antioxidant can be problematic

Key Publications

Cross-links

• [NQO1 Gene](/genes/nqo1) — Gene page for NQO1
• [Alzheimer's Disease](/diseases/alzheimers-disease) — Disease page with NQO1 involvement
• [Parkinson's Disease](/diseases/parkinsons-disease) — Disease page with NQO1 involvement
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis) — Disease page with NQO1 involvement
• [Oxidative Stress Pathway](/mechanisms/oxidative-stress) — Core mechanism
• [Nrf2 Signaling Pathway](/mechanisms/nrf2-signaling) — Related pathway

External Links

• [Human Protein Atlas: NQO1](https://www.proteinatlas.org/ENSG00000181019-NQO1)
• [UniProt: NQO1](https://www.uniprot.org/uniprotkb/P15559)
• [PDGene: NQO1](https://www.pdgene.org/gene.4112)

See Also

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• [Oxidative Stress Pathway](/mechanisms/oxidative-stress)
• [Nrf2 Signaling Pathway](/mechanisms/nrf2-signaling)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving NQO1 Protein (NAD(P)H Quinone Dehydrogenase 1) discovered through SciDEX knowledge graph analysis: